Virtu Financial’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-78,454
| Closed | -$78K | – | 1645 |
|
|
2024
Q2 | $78K | Buy |
+78,454
| New | +$78K | 0.01% | 852 |
|
|
2023
Q2 | – | Sell |
-17,521
| Closed | -$26K | – | 1791 |
|
|
2023
Q1 | $26K | Sell |
17,521
-26,921
| -61% | -$39.9K | ﹤0.01% | 1197 |
|
|
2022
Q4 | $52K | Buy |
44,442
+34,414
| +343% | +$40.3K | 0.01% | 1074 |
|
|
2022
Q3 | $11K | Sell |
10,028
-3,352
| -25% | -$3.68K | ﹤0.01% | 1506 |
|
|
2022
Q2 | $21K | Buy |
+13,380
| New | +$21K | ﹤0.01% | 1320 |
|
|
2021
Q3 | – | Sell |
-54,131
| Closed | -$154K | – | 1746 |
|
|
2021
Q2 | $154K | Buy |
+54,131
| New | +$154K | 0.02% | 1081 |
|
|
2020
Q4 | – | Sell |
-40,318
| Closed | -$38K | – | 1620 |
|
|
2020
Q3 | $38K | Sell |
40,318
-37,724
| -48% | -$35.6K | 0.01% | 849 |
|
|
2020
Q2 | $68K | Buy |
+78,042
| New | +$68K | 0.01% | 958 |
|
|
2019
Q1 | – | Sell |
-34,884
| Closed | -$32K | – | 1645 |
|
|
2018
Q4 | $32K | Buy |
+34,884
| New | +$32K | ﹤0.01% | 1320 |
|
|
2018
Q1 | – | Sell |
-119,836
| Closed | -$225K | – | 2294 |
|
|
2017
Q4 | $225K | Buy |
119,836
+101,293
| +546% | +$190K | 0.01% | 1543 |
|
|
2017
Q3 | $46K | Buy |
+18,543
| New | +$46K | ﹤0.01% | 2240 |
|